Article Sidebar
Main Article Content
Abstract
RÉSUMÉ
Introduction. Le glaucome secondaire est une cause importante de cécité, souvent associée à des tumeurs intraoculaires mal diagnostiquées. Cette revue vise à identifier les tumeurs responsables de glaucome réfractaire et à évaluer l’apport de l’imagerie médicale dans leur diagnostic. Matériels et méthodes. Une revue a été réalisée sur PubMed, Embase, Cochrane, Google Scholar, Pan African Journal, Ophthalmology Clinics et la Société Française d’Ophtalmologie, couvrant la période 1996–2023. Cinquante-sept études répondant aux critères d’inclusion ont été retenues. Résultats. Les tumeurs les plus fréquemment associées au glaucome réfractaire étaient le rétinoblastome (23,6%), le mélanome choroïdien (10,9%) et le médulloépithéliome (10,9%). L’imagerie médicale (tomodensitométrie, IRM) a permis un diagnostic précis dans la majorité des cas. Conclusion. En cas de glaucome résistant au traitement, un diagnostic différentiel incluant une tumeur intraoculaire doit être envisagé, avec recours à l’imagerie médicale pour une prise en charge adaptée.
ABSTRACT
Introduction. Secondary glaucoma is a major cause of blindness, often associated with misdiagnosed intraocular tumors. This review aims to identify tumors responsible for refractory glaucoma and assess the role of medical imaging in their diagnosis. Materials and methods. A brief review was conducted using PubMed, Embase, Cochrane, Google Scholar, Pan African Journal, Ophthalmology Clinics, and the French Society of Ophthalmology, covering 1996–2023. Fifty-seven studies meeting inclusion criteria were included. Results. The most frequent tumors associated with refractory glaucoma were retinoblastoma (23.6%), choroidal melanoma (10.9%), and medulloepithelioma (10.9%). Medical imaging (CT, MRI) enabled accurate diagnosis in most cases. Conclusion. In treatment-resistant glaucoma, a differential diagnosis including intraocular tumors should be considered, with medical imaging for appropriate management.
Keywords
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
- 1. Nick Strouthidis M. et FRCO FRANZCO. (2014). the charity for people with glaucoma. Dans Secondary Glaucomas (p. 18–19). Jayaram MA BMBCH PhD FRCSEd FRCOphth Clinical Lecturer, Glaucoma Service, Moorfields Eye Hospital.
- 2. Nathan M. Radcliffe et Paul T. Finger. (2009). Eye cancer related glaucoma: current concepts Surv Ophthalmol, 54(1), 47–73.
- 3. Manli Zhao. (2014). Secondary glaucoma as initial manifestation of ring melanoma: A case report and review of literature. International Journal of Clinical and Experimental Pathology 7(11):8163-9
- 4. Chakma P, P. D. (2021). A Clinical Study of Secondary Glaucoma with Special Reference to ItsProportion, Causes and Its Risk Factors in a Tertiary Care Hospital- A Cross Sectional Study. Jebmh, 8(1), 23-27
- 5. Camp DA, Yadav P, Dalvin LA, Shields CL. Glaucoma secondary to intraocular tumors: mechanisms and management. Curr Opin Ophthalmol. 2019 Mar;30(2):71-81.
- 6. Tong, M.G., Ozment, R.R., Chen, T.C. (2022). Ocular Tumors and Glaucoma. In: Albert, D.M., Miller, J.W., Azar, D.T., Young, L.H. (eds) Albert and Jakobiec's Principles and Practice of Ophthalmology. Springer, Cham.
- 7. Quigley HA. The number of people with glaucoma worldwide. Br J Ophthalmology 1996;80(5):389-393.
- 8. Shields CL Shah SU Bianciotto CG Emrich J. Komarnicky L. Shields JA. (2013). Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients : Impact of melanoma related glaucoma on outcomes. Ophthalmology, 120(3), 55–61.
- 9. Yang, M et al. (2015). Eye Tumors Misdiagnosed as Glaucoma. Chinese Medical Journal, 128(2), 273.
- 10. Nathan M. Radcliffe. Paul T. Finger. (2009). Eye cancer related glaucoma : current concepts. Surv Ophthalmol, 54(1), 47–73.
- 11. Arash Mansouri MD, Leon W, Herndon MD. (1999). Glaucoma as the initial manifestation of ocular malignancy. ophthalmology Clinics of north America, 12(2), 197–204.
- 12. Marshal C.D. (1896). On tension in cases of intra-ocular tumour. Transactions of the Ophthalmological Societies of the United Kingdom; 16: 155
- 13. Teichmann K.D. Karcioglu Z.A. (1995). Melanocytoma of the iris with rapidly developing secondary glaucoma. Surv Ophthalmol.; 40: 136.
- 14. Hari Jayaram and Nick Strouthidis. Secondary Glaucomas Moorfields Eye Hospital. Woodcote House, Ashford, Kent TN24 8DH ; Glaucoma UK.
- 15. Ramakrishnan R, Nirmalan PK, Krishnadas R, et al. (2003). Glaucoma in a rural population of southern India: The Aravind comprehensive eye survey. Ophthalmology;110(8):1484-1490.
- 16. Das J, Bhomaj S, Chaudhuri Z, et al. (2001). Profile of glaucoma in a major eye hospital in North India. Indian J Ophthalmol; 49(1):25-30.
- 17. Gadia R, Sihota R, Dada T, et al. (2008). Current profile of secondary glaucomas. Indian J Ophthalmol; 56(4):285-289.
- 18. Qureshi MB, Khan MD, Shah MN, et al. (2006). Glaucoma admissions and surgery in public sector tertiary care hospitals in Pakistan: results of a National study. Ophthalmic Epidemiolol; Vol 13(2):115-119.
- 19. Teikari JM, O’Donnell J. (1989). Epidemiologic data on adult glaucomas: data from the hospital discharge registry and the registry of right to free medication. Acta Ophthalmol (Copenh). Vol 67(2):184-191.
- 20. Yamamoto T, Iwase A, Araie M, et al. (2005). The Tajimi Study report 2-prevalence of primary angle closure and secondary glaucoma in a Japanese population. Ophthalmology. Vol 112 (10):1661-1669.
- 21. E. Bohere, N. Franquet F. Delanoy, A.Scheffer, G. Laverdure. (2009). Intérêt de l’imagerie cérébrale dans le diagnostic de glaucome à pression normaleNeuroimaging in diagnosis of normal tension glaucoma. Journal Français d'Ophtalmologie. Vol 32(1), Elsevier Masson, P.12-155
References
1. Nick Strouthidis M. et FRCO FRANZCO. (2014). the charity for people with glaucoma. Dans Secondary Glaucomas (p. 18–19). Jayaram MA BMBCH PhD FRCSEd FRCOphth Clinical Lecturer, Glaucoma Service, Moorfields Eye Hospital.
2. Nathan M. Radcliffe et Paul T. Finger. (2009). Eye cancer related glaucoma: current concepts Surv Ophthalmol, 54(1), 47–73.
3. Manli Zhao. (2014). Secondary glaucoma as initial manifestation of ring melanoma: A case report and review of literature. International Journal of Clinical and Experimental Pathology 7(11):8163-9
4. Chakma P, P. D. (2021). A Clinical Study of Secondary Glaucoma with Special Reference to ItsProportion, Causes and Its Risk Factors in a Tertiary Care Hospital- A Cross Sectional Study. Jebmh, 8(1), 23-27
5. Camp DA, Yadav P, Dalvin LA, Shields CL. Glaucoma secondary to intraocular tumors: mechanisms and management. Curr Opin Ophthalmol. 2019 Mar;30(2):71-81.
6. Tong, M.G., Ozment, R.R., Chen, T.C. (2022). Ocular Tumors and Glaucoma. In: Albert, D.M., Miller, J.W., Azar, D.T., Young, L.H. (eds) Albert and Jakobiec's Principles and Practice of Ophthalmology. Springer, Cham.
7. Quigley HA. The number of people with glaucoma worldwide. Br J Ophthalmology 1996;80(5):389-393.
8. Shields CL Shah SU Bianciotto CG Emrich J. Komarnicky L. Shields JA. (2013). Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients : Impact of melanoma related glaucoma on outcomes. Ophthalmology, 120(3), 55–61.
9. Yang, M et al. (2015). Eye Tumors Misdiagnosed as Glaucoma. Chinese Medical Journal, 128(2), 273.
10. Nathan M. Radcliffe. Paul T. Finger. (2009). Eye cancer related glaucoma : current concepts. Surv Ophthalmol, 54(1), 47–73.
11. Arash Mansouri MD, Leon W, Herndon MD. (1999). Glaucoma as the initial manifestation of ocular malignancy. ophthalmology Clinics of north America, 12(2), 197–204.
12. Marshal C.D. (1896). On tension in cases of intra-ocular tumour. Transactions of the Ophthalmological Societies of the United Kingdom; 16: 155
13. Teichmann K.D. Karcioglu Z.A. (1995). Melanocytoma of the iris with rapidly developing secondary glaucoma. Surv Ophthalmol.; 40: 136.
14. Hari Jayaram and Nick Strouthidis. Secondary Glaucomas Moorfields Eye Hospital. Woodcote House, Ashford, Kent TN24 8DH ; Glaucoma UK.
15. Ramakrishnan R, Nirmalan PK, Krishnadas R, et al. (2003). Glaucoma in a rural population of southern India: The Aravind comprehensive eye survey. Ophthalmology;110(8):1484-1490.
16. Das J, Bhomaj S, Chaudhuri Z, et al. (2001). Profile of glaucoma in a major eye hospital in North India. Indian J Ophthalmol; 49(1):25-30.
17. Gadia R, Sihota R, Dada T, et al. (2008). Current profile of secondary glaucomas. Indian J Ophthalmol; 56(4):285-289.
18. Qureshi MB, Khan MD, Shah MN, et al. (2006). Glaucoma admissions and surgery in public sector tertiary care hospitals in Pakistan: results of a National study. Ophthalmic Epidemiolol; Vol 13(2):115-119.
19. Teikari JM, O’Donnell J. (1989). Epidemiologic data on adult glaucomas: data from the hospital discharge registry and the registry of right to free medication. Acta Ophthalmol (Copenh). Vol 67(2):184-191.
20. Yamamoto T, Iwase A, Araie M, et al. (2005). The Tajimi Study report 2-prevalence of primary angle closure and secondary glaucoma in a Japanese population. Ophthalmology. Vol 112 (10):1661-1669.
21. E. Bohere, N. Franquet F. Delanoy, A.Scheffer, G. Laverdure. (2009). Intérêt de l’imagerie cérébrale dans le diagnostic de glaucome à pression normaleNeuroimaging in diagnosis of normal tension glaucoma. Journal Français d'Ophtalmologie. Vol 32(1), Elsevier Masson, P.12-155